Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

(The Express Wire via Comtex)

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets Provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

Description

Summary

The global market for chronic disease management therapeutics and device technologies was worth REDACTED in 2018. The market is expected to reach REDACTED in 2019 and REDACTED by 2024, increasing at a compound annual growth rate (CAGR) of REDACTED from 2019 through 2024. This market growth is fueled by a growing geriatric population, changing lifestyle, increasing prevalence of chronic diseases, superior clinical results of new drugs and biologics, increasing trend of digital health, the U.S. Patient Protection and Affordable Care Act, increasing awareness in the developed world, strong research and development (RandD) initiatives from key market players, increasing government initiatives, patient assistance programs, regulatory efforts to provide smooth regulatory approval process, adoptionof portable/wearable device technologies and adoption of advanced software applications; further, keydrivers for the market include smart pills, targeted therapy, advanced needle-free drug deliverytechnologies, drug-device combinations and development of home-care and self-medication devices.

Access the PDF sample of the report @https://www.orbisresearch.com/contacts/request-sample/3944220

However, some of the key market barriers are lack of awareness in
underdeveloped countries, poormedication adherence, patent expiry blockbuster drugs and biologics, shorter product life cycles fordevice technologies, regulatory issues (stringent regulatory approval procedure), increasing RandD cost,health disparities in in low-income countries, higher cost of the cancer treatment, data privacy, datasecurity and data accuracy.

In 2018, the U.S. accounted for REDACTED of the global market, or REDACTED. The U.S. market should approach REDACTED in 2019 and reach REDACTED by 2024, increasing at a CAGR of REDACTED from 2019 through 2024. Regionally, the U.S. is expected to maintain dominance in the therapeutics and device technologies segments of global chronic disease management market. Those wishing to invest in the chronic disease management therapeutics and device technologies market ought to strongly consider high-growth areas such as pharmaceutical drugs, biologics, medical device technologies and software applications.

Report Scope:

Chronic disease management includes various drug and medical device-based techniques used for the management of various chronic diseases. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for chronic disease management through various therapeutics and advanced device technologies. The format of this study includes the following -
- Detailed description, including demographics and cost burden, of various chronic diseases including cancer, diabetes, cardiovascular disorders, respiratory diseases, musculoskeletal disorders, neurological disorders, GI diseases, immune disorders, mental disorders and others (ostomy, urology disorders, chronic wounds etc.).
- Detailed description and analysis of current therapeutics (drugs, biologics) and device technologies (traditional medical devices, drug-device combinations, wearable and other monitoring devices).
- Market characterization, unmet need, market size and segmentation (by region, by segment, by diseases, by drug delivery, by treatment adherence, by health settings).
- Market drivers and restraints.
- Detailed market projections through 2024.
- Competition and market shares.
- Key marketed and pipeline (research and development) products along with information about their regulatory status.
- Strategic landscape (mergers and acquisitions).
- Regulatory structure.
- Pricing and reimbursement.
- Observations and conclusions on the future of chronic disease management.
- Profiles of market participants and associations.

Report Includes:

- 30 data tables and 46 additional tables
- Brief outline of the global markets and therapeutic device technologies for chronic disease management
- Analyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Key insight into the current state of chronic diseases and disorders, with an emphasis on advance needle-free drug delivery technologies, diagnostic methods, and smart device technologies that support effective disease state management
- Data corresponding to global chronic disease management markets by disease type that includes various chronic diseases, therapeutic drugs, treatment adherence devices and systems, drug delivery technologies, and treatment and management providers
- Regulatory structure for pharmaceuticals and medical devices, pricing and reimbursement structure, marketed and pipeline products, and major developments influencing the market
- Detailed company profiles and competitive landscape of major market players, including Roche, AbbVie, Johnson and Johnson, Bristol-Myers Squibb, Merck and GlaxoSmithKline

Companies Mentioned:
3RINGS
ABBOTT LABORATORIES
ABBVIE INC.
ACADIA PHARMACEUTICAL
ACORDA THERAPEUTICS
ACTAVIS PLC
ACTUALMEDS
ADHERIUM
AGENUS
AKRON
ALIPHCOM
ALIVECOR
ALKERMES
ALLERGAN
AMGEN INC.
AMIKO
AMNEAL PHARMACEUTICALS
ANAVEX LIFE SCIENCES
ANI PHARMACEUTICALS
ANIMAS (A SUBSIDIARY OF JOHNSON and JOHNSON)
APOTEX
ARCHOS
ARENA PHARMACEUTICALS
ARRAY BIOPHARMA
ASAHI KASAI CORP.
ASLAN PHARMACEUTICALS
ASPEN PHARMACARE
ASTELLAS PHARMA INC.
ASTRAZANECA PLC
ATHERSYS
AUDENTES THERAPEUTICS
AXIOBIONICS
AXSOME THERAPEUTICS
AYOGO HEALTH
BAUSCH HEALTH
BAYER AG
BEIGENE
BESPAK EUROPE
BIOSENSICS
BIOSERENITY
BIOTRICITY
BIOTRONIK GMBH
BIOVOTION
BIOXCEL THERAPEUTICS
BODYTEL
BOEHRINGER INGELHEIM
BOSTON SCIENTIFIC
BRAINMARC
BRISTOL-MYERS SQUIBB
BTS BIOENGINEERING
CARDIOMEMS INC. (A SUBSIDIARY OF ST. JUDE)
CELGENE
CHUGAI PHARMACEUTICALS CO., LTD.
CIPLA
CLEVELAND MEDICAL DEVICE
CLOVIS ONCOLOGY
CONNECTEDHEALTH PTE. LTD.
CORBUS PHARMACEUTICALS
CSPC PHARMACEUTICAL GROUP
DAIICHI SANKYO
DEPOMED INC.
DEXCOM INC.
DR. REDDY'S LABORATORIES LTD.
EARLYSENSE
EDWARDS LIFESCIENCES CORP.
EISAI
ELI LILLY
EMPATICA
ENDO INTERNATIONAL
ENDOCEUTICS INC.
ENDOTRONIX
ENTRA HEALTH SYSTEMS
ERYTECH PHARMA
ESTEVE
EVERIST HEALTH
FIVE PRIME THERAPEUTICS
GILEAD SCIENCES
GLAXOSMITHKLINE PLC
GLOOKO, INC.
GLUCOVISTA INC.
GOODLUX TECHNOLOGY LLC
HALOZYME THERAPEUTICS
HEALTH CARE ORIGINALS
HIKMA PHARMACEUTICALS
HOCOMA
IHEALTH
IMMUNOMEDICS
IMPACT SPORTS TECHNOLOGIES
IMPAK HEALTH
INFOBIONIC INC.
INSULET CORP.
INTELESENS
INTRA-CELLULAR THERAPIES
IOVANCE BIOTHERAPEUTICS
IPSEN S.A.
JAN MEDICAL INC.
JIANGSU HENGRUI MEDICINE
JOHNSON and JOHNSON
KYOWA HAKKO KIRIN
LES LABORATOIRES SERVIER
LIVANOVA PLC
LUNDBECK
LUPIN
MALLINCKRODT PLC
MEDCONNECTIONS INC.
MEDMINDER
MEDTRONIC
MEDTRONIC MINIMED INC. (A SUBSIDIARY OF MEDTRONIC)
MENARINI
MERCK
MIO GLOBAL
MITSUBISHI TANABE PHARMA
MYCARDIO LLC
MYLAN INC.
NEMAURA MEDICAL INC.
NEOFECT CO., LTD.
NEUROCRINE BIOSCIENCES
NEUROMETRIX INC.
NEUROVIGIL INC.
NOVARTIS
NOVASOM INC.
NOVO NORDISK
NUCANA
OMADA HEALTH INC.
OMNICELL INC.
OMRON CORP.
ONO PHARMACEUTICAL CO., LTD.
ORION PHARMA LTD.
ORPYX MEDICAL TECHNOLOGIES
OTSUKA PHARMACEUTICALS
PACIRA PHARMACEUTICALS INC.
PFIZER
PHILOSYS
POLAR ELECTRO OY
PRESCRIBEWELLNESS LLC
PREVENTICE INC.
PRIZM MEDICAL INC.
PROPELLER HEALTH
PROTEOSTASIS THERAPEUTICS
PROTEUS DIGITAL HEALTH INC.
QARDIO
REHAB-ROBOTICS (A MEMBER OF VINCENT MEDICAL HOLDINGS)
REXAHN PHARMACEUTICALS
ROCHE
SAGE THERAPEUTICS
SANOFI
SAREPTA THERAPEUTICS
SENSE4CARE
SENSEONICS HOLDINGS
SENTICARE INC.
SHANGHAI PHARMACEUTICALS HOLDING
SHIONOGI AND CO., LTD.
SILVERGENS
SPROUTLING INC. (ACQUIRED BY MANTTEL)
ST. JUDE MEDICAL (A SUBSIDIARY OF ABBOTT LABORATORIES)
STADA ARZNEIMITTEL AG
SUMITOMO DAINIPPON PHARMA CO., LTD.
SUN PHARMACEUTICAL INDUSTRIES
TAISHO PHARMACEUTICAL
TAKEDA PHARMACEUTICAL CO., LTD.
TCR2 THERAPEUTICS
TEVA PHARMACEUTICAL INDUSTRIES
TOWERVIEW HEALTH, INC.
TRANSLATE BIO
TYME TECHNOLOGIES
UCB
UNILIFE CORP.
VAICA
VERTEX PHARMACEUTICAL
VITAL CONNECT
WEST PHARMACEUTICAL SERVICES INC.
WINMEDICAL SRL
YBRAIN
YPSOMED HOLDING AG
ZOGENIX INC.
ZYDUS CADILA

Browse the full report @https://www.orbisresearch.com/reports/index/chronic-disease-management-therapeutics-device-technologies-and-global-markets

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Chronic Diseases and Growing Burden on Economy
Background of Chronic Diseases
Epidemiology and Global Burden
Chronic Diseases Types
Cardiovascular Disease
Lifestyle Disorders
Cancer
Respiratory Disorders
Musculoskeletal Disorders
Mental/Mood Disorders
Gastro-Intestinal Disorders
Immune Disorders
Neurological Disorders
Other Chronic Disorders
Tobacco Smoking and Chronic Diseases
Aging, Gender and Chronic Diseases
Global Demographics
U.S. Demographics
U.S: Gender, Age and Life Expectancy
European Demographics
Japanese Demographics
Current Challenges and Future Directions
Chapter 4 Chronic Diseases: Therapeutics
Therapeutics and Chronic Diseases
Generic Drugs and Chronic Diseases
Generic Drugs vs. Branded Drugs
Continued Resistance for Generics
Biologics and Biosimilars for Immune-Mediated Chronic Diseases
Cancer and Targeted Therapy
Clinical Need of Therapeutics
Therapeutics and Cost Burden
Chronic Diseases and Managed Care
Key Marketed and Pipeline Products
Key Marketed Products
Key Pipeline/RandD Products
Unmet Need
Current Challenges and Future Developments
Chapter 5 Device Technologies and Applications
Medical Devices and Chronic Disease Management
Clinical and Market Need of Digital Therapeutics
Types of Device Technologies
Diagnostic and Monitoring Devices
Therapeutic Devices and Technologies
Key Marketed and RandD/Pipeline Products
Diagnostic and Monitoring Devices
Therapeutic Devices and Technologies
Advantages of Chronic Disease Management via Digital Care
Unmet Need
Future Developments for Healthcare and Safety Monitoring
Current Challenges
Future Outlook
Chapter 6 Chronic Diseases: Treatment Adherence Devices and Applications
Treatment Nonadherence
Market Need for Medication Adherence Systems and Applications
Types of Medication Adherence Systems and Applications
Hardware-Centric Medication Adherence Systems
Medication Adherence Software Applications
Key Marketed and Pipeline Products
Hardware-Centric Medication Adherence Systems
Medication Adherence Software Applications
Software and Mobile Application Advantages
Interconnectivity of Adherence App
Effectiveness of Smartphone Adherence Apps
Current Challenges
Future Developments
Chapter 7 Market Size and Growth Analysis
Market Size and Growth Analysis
Market Size and Growth Analysis, by Region
Market Size and Growth Analysis, by Product Segment
Market Size and Growth Analysis, by Chronic Disease Type
Market Size and Growth Analysis, by Treatment Provider and Target Health Settings
Market Growth Drivers and Restraints
Market Growth Drivers
Market Restraints
Chapter 8 Competitive Landscape in the Chronic Disease Management Market
Competitive Landscape: Chronic Disease Management with New Therapeutics and Advanced Device Technologies
Chapter 9 Strategies in the Chronic Disease Management Market
Consolidation in the Chronic Disease Management Market
Mergers and Acquisitions in the Chronic Disease Management Market
Recent Mergers and Acquisitions
Device Technologies
Therapeutics (Drugs and Biologics)
Minority Stakes and Future Options to Acquire
Future Strategic Landscape
Chapter 10 Regulatory Structure: Pharmaceuticals and Medical Devices
Regulatory Background
Regulatory Systems for Medical Devices, by Region
U.S.
European Union
Japan
Regulatory Systems for Pharmaceuticals, by Region
U.S.
Europe
Japan
Chapter 11 Pricing and Reimbursement: Pharmaceuticals and Medical Devices
Pricing and Reimbursement Background
Pricing and Reimbursement for Medical Devices, by Region
U.S.
Europe
Japan
Other Asia-Pacific
Pricing and Reimbursement for Pharmaceuticals, by Region
U.S.
Europe
Japan
Chapter 12 Conclusions - Outlook for Chronic Disease Management
Major Developments Influencing the Market
Technological Developments
Demographic and Economic Trends
Changing Structure of the Healthcare Industry
Lifestyle Medicine
Patient-Centric Programs
Long-Term Outlook for Chronic Disease Management
Chapter 13 Company Profiles
3RINGS
ABBOTT LABORATORIES
ABBVIE INC.
ACADIA PHARMACEUTICAL
ACORDA THERAPEUTICS
ACTUALMEDS
AGENUS
ACTAVIS PLC
ADHERIUM
AKRON
ALIVECOR
AMGEN INC.
AMIKO
ANIMAS (A SUBSIDIARY OF JOHNSON and JOHNSON)
ANI PHARMACEUTICALS
ALIPHCOM
ALLERGAN
ALKERMES
AMNEAL PHARMACEUTICALS
ANAVEX LIFE SCIENCES
APOTEX
ARCHOS
ARENA PHARMACEUTICALS
ARRAY BIOPHARMA
ASLAN PHARMACEUTICALS
ASAHI KASAI CORP.
ASPEN PHARMACARE
ASTRAZANECA PLC
ASTELLAS PHARMA INC.
ATHERSYS
AUDENTES THERAPEUTICS
AXIOBIONICS
AXSOME THERAPEUTICS
AYOGO HEALTH
BAUSCH HEALTH
BAYER AG
BESPAK EUROPE
BEIGENE
BIOXCEL THERAPEUTICS
BIOSENSICS
BIOSERENITY
BIOTRONIK GMBH
BIOTRICITY
BIOVOTION
BODYTEL
BOEHRINGER INGELHEIM
BOSTON SCIENTIFIC
BRISTOL-MYERS SQUIBB
BRAINMARC
BTS BIOENGINEERING
CARDIOMEMS INC. (A SUBSIDIARY OF ST. JUDE)
CELGENE
CHUGAI PHARMACEUTICALS CO., LTD.
CIPLA
CLEVELAND MEDICAL DEVICE
CLOVIS ONCOLOGY
CONNECTEDHEALTH PTE. LTD.
CORBUS PHARMACEUTICALS
CSPC PHARMACEUTICAL GROUP
DAIICHI SANKYO
DEXCOM INC.
DEPOMED INC.
DR. REDDY'S LABORATORIES LTD.
EARLYSENSE
EDWARDS LIFESCIENCES CORP.
EISAI
ELI LILLY
EMPATICA
ENDO INTERNATIONAL
ENDOTRONIX
ENTRA HEALTH SYSTEMS
ENDOCEUTICS INC.
ERYTECH PHARMA
ESTEVE
EVERIST HEALTH
FIVE PRIME THERAPEUTICS
GLAXOSMITHKLINE PLC
GLOOKO, INC.
GILEAD SCIENCES
GLUCOVISTA INC.
GOODLUX TECHNOLOGY LLC
HALOZYME THERAPEUTICS
HEALTH CARE ORIGINALS
HIKMA PHARMACEUTICALS
HOCOMA
IHEALTH
IMMUNOMEDICS
IMPACT SPORTS TECHNOLOGIES
IMPAK HEALTH
INFOBIONIC INC.
INSULET CORP.
INTELESENS
INTRA-CELLULAR THERAPIES
IOVANCE BIOTHERAPEUTICS
IPSEN S.A.
JAN MEDICAL INC.
JIANGSU HENGRUI MEDICINE
JOHNSON and JOHNSON
LUNDBECK
LUPIN
KYOWA HAKKO KIRIN
LES LABORATOIRES SERVIER
LIVANOVA PLC
MALLINCKRODT PLC
MEDTRONIC
MEDTRONIC MINIMED INC. (A SUBSIDIARY OF MEDTRONIC)
MEDCONNECTIONS INC.
MEDMINDER
MENARINI
MERCK
MIO GLOBAL
MITSUBISHI TANABE PHARMA
MYLAN INC.
MYCARDIO LLC
NEMAURA MEDICAL INC.
NEOFECT CO., LTD.
NEUROCRINE BIOSCIENCES
NEUROMETRIX INC.
NEUROVIGIL INC.
NOVARTIS
NOVO NORDISK
NOVASOM INC.
NUCANA
OMADA HEALTH INC.
OMRON CORP.
OMNICELL INC.
ONO PHARMACEUTICAL CO., LTD.
ORION PHARMA LTD.
ORPYX MEDICAL TECHNOLOGIES
OTSUKA PHARMACEUTICALS
PACIRA PHARMACEUTICALS INC.
PFIZER
PHILOSYS
POLAR ELECTRO OY
PREVENTICE INC.
PRESCRIBEWELLNESS LLC
PRIZM MEDICAL INC.
PROPELLER HEALTH
PROTEUS DIGITAL HEALTH INC.
PROTEOSTASIS THERAPEUTICS
QARDIO
REHAB-ROBOTICS (A MEMBER OF VINCENT MEDICAL HOLDINGS)
REXAHN PHARMACEUTICALS
ROCHE
SAGE THERAPEUTICS
SANOFI
SAREPTA THERAPEUTICS
SENSE4CARE
SENSEONICS HOLDINGS
SENTICARE INC.
SHANGHAI PHARMACEUTICALS HOLDING
SHIONOGI AND CO., LTD.
SILVERGENS
SPROUTLING INC. (ACQUIRED BY MANTTEL)
ST. JUDE MEDICAL (A SUBSIDIARY OF ABBOTT LABORATORIES)
STADA ARZNEIMITTEL AG
SUMITOMO DAINIPPON PHARMA CO., LTD.
SUN PHARMACEUTICAL INDUSTRIES
TAKEDA PHARMACEUTICAL CO., LTD.
TAISHO PHARMACEUTICAL
TCR2 THERAPEUTICS
TEVA PHARMACEUTICAL INDUSTRIES
TOWERVIEW HEALTH, INC.
TRANSLATE BIO
TYME TECHNOLOGIES
UCB
UNILIFE CORP.
VERTEX PHARMACEUTICAL
VAICA
VITAL CONNECT
WEST PHARMACEUTICAL SERVICES INC.
WINMEDICAL SRL
YBRAIN
YPSOMED HOLDING AG
ZOGENIX INC.
ZYDUS CADILA
Chapter 14 Appendix A: List of Acronyms
Chapter 15 Appendix B: Professional Organizations
American Heart Association
Center for Drug Evaluation and Research (CDER)
Center for Devices and Radiological Health (CDRH)
Centers for Medicare and Medicaid Services (CMS)
European Databank for Medical Devices (EUDAMED)
Food and Drug Administration (FDA or USFDA)
Hormone Foundation
International Diabetes Federation (IDF)
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
Network for Excellence in Health Innovation (NEHI)
National Center for Biotechnology Information (NCBI)
National Institute of Aging (NIA)
Pharmaceuticals and Medical Devices Agency (PMDA)
World Cancer Research Fund International
World Health Organization (WHO)

Direct purchase the report @https://www.orbisresearch.com/contact/purchase-single-user/3944220

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Chronic Disease Management: Therapeutics, Device Technologies and Global Markets